Morgan Stanley (NYSE:MS) CFO Jonathan Pruzan sold 52,204 shares of Morgan Stanley stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $55.35, for a total value of $2,889,491.40. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Morgan Stanley (NYSE:MS) traded down $0.26 during mid-day trading on Friday, hitting $55.14. The company’s stock had a trading volume of 7,448,195 shares, compared to its average volume of 10,390,000. Morgan Stanley has a 1 year low of $40.06 and a 1 year high of $58.05. The company has a debt-to-equity ratio of 2.68, a current ratio of 0.74 and a quick ratio of 0.74. The stock has a market cap of $99,690.00, a P/E ratio of 17.84, a price-to-earnings-growth ratio of 0.95 and a beta of 1.54.
Morgan Stanley (NYSE:MS) last posted its earnings results on Thursday, January 18th. The financial services provider reported $0.84 earnings per share for the quarter, topping analysts’ consensus estimates of $0.77 by $0.07. Morgan Stanley had a return on equity of 10.03% and a net margin of 14.10%. The firm had revenue of $9.50 billion for the quarter, compared to the consensus estimate of $9.25 billion. During the same quarter in the prior year, the business earned $0.81 EPS. The business’s revenue for the quarter was up 5.3% on a year-over-year basis. research analysts forecast that Morgan Stanley will post 4.51 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Wednesday, January 31st were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Tuesday, January 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.81%. Morgan Stanley’s dividend payout ratio (DPR) is 32.36%.
Several hedge funds have recently bought and sold shares of MS. Exane Derivatives grew its holdings in shares of Morgan Stanley by 303.9% during the 4th quarter. Exane Derivatives now owns 1,979 shares of the financial services provider’s stock worth $104,000 after acquiring an additional 1,489 shares during the period. Invictus RG boosted its position in shares of Morgan Stanley by 307.5% in the 3rd quarter. Invictus RG now owns 2,335 shares of the financial services provider’s stock worth $112,000 after purchasing an additional 1,762 shares in the last quarter. Rational Advisors LLC bought a new stake in shares of Morgan Stanley in the 3rd quarter worth approximately $116,000. Zions Bancorporation boosted its position in shares of Morgan Stanley by 176.1% in the 3rd quarter. Zions Bancorporation now owns 2,463 shares of the financial services provider’s stock worth $119,000 after purchasing an additional 1,571 shares in the last quarter. Finally, WFG Advisors LP boosted its position in shares of Morgan Stanley by 45.4% in the 2nd quarter. WFG Advisors LP now owns 2,690 shares of the financial services provider’s stock worth $120,000 after purchasing an additional 840 shares in the last quarter. Hedge funds and other institutional investors own 86.55% of the company’s stock.
Several equities research analysts have issued reports on MS shares. Royal Bank of Canada reaffirmed a “buy” rating and set a $60.00 price target on shares of Morgan Stanley in a research note on Friday, January 19th. Wells Fargo & Co set a $55.00 price target on Morgan Stanley and gave the company a “hold” rating in a report on Wednesday, December 20th. Zacks Investment Research upgraded Morgan Stanley from a “hold” rating to a “buy” rating and set a $59.00 price target on the stock in a report on Wednesday, January 3rd. Keefe, Bruyette & Woods restated a “buy” rating and set a $63.00 price target on shares of Morgan Stanley in a report on Friday, December 22nd. Finally, UBS Group upgraded Morgan Stanley to an “overweight” rating in a report on Wednesday, January 10th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the stock. Morgan Stanley presently has a consensus rating of “Buy” and a consensus target price of $54.07.
WARNING: This piece of content was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of US and international copyright law. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/16/morgan-stanley-ms-cfo-sells-2889491-40-in-stock.html.
About Morgan Stanley
Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.